ClinicalTrials.gov detail: full record for a single study by NCT id. Returns the...

{ "method": "GET", "queryParams": { "nct": "NCT03548935" }, "type": "http" }

{ "example": { "collaborators": [], "completion_date": "2021-03-29", "conditions": [ "Metabolism and Nutrition Disorder", "Overweight or Obesity" ], "countries": [ "United States", "Argentina" ], "eligibility": "Inclusion Criteria:\n\nMain phase:\n\n* Male or female, age greater than or equal to 18 years at the time of signing informed consent…", "enrollment": 1961, "has_results": true, "interventions": [ { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo (semaglutide)", "type": "DRUG" } ], "locations_count": 129, "max_age": null, "min_age": "18 Years", "nct_id": "NCT03548935", "official_title": "Effect and Safety of Semaglutide 2.4 mg Once-weekly in Subjects With Overweight or Obesity", "phase": "PHASE3", "primary_outcomes": [ { "measure": "Change in Body Weight (%)", "time_frame": "Baseline (week 0) to week 68" } ], "sex": "ALL", "source": "ClinicalTrials.gov", "sponsor": "Novo Nordisk A/S", "start_date": "2018-06-04", "status": "COMPLETED", "study_type": "INTERVENTIONAL", "summary": "This study will look at the change in participants' body weight from the start to the end of the study. The weight loss in participants taking semaglutide (a new medicine) will be compared to the weight loss of participants taking \"dummy\" medicine…", "title": "STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity", "url": "https://clinicaltrials.gov/study/NCT03548935" }, "type": "json" }